Where I see patients (1)
Selected research
-
Tumor heterogeneity underlies clinical outcome and MEK inhibitor response in somatic NF1-mutant glioblastoma.
JCI insight
-
Understanding and imaging PHGDH-driven intrinsic resistance to mutant IDH inhibition in gliomas.
bioRxiv : the preprint server for biology
-
3D spatial sampling to quantify morphologic heterogeneity in isocitrate dehydrogenase-wildtype glioblastoma.
Journal of neuropathology and experimental neurology